Skip to content

Clinical trials

Completed Phase 1 Overweight trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Phase: Phase 1 Status: Completed Clear all

174 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20054
20062
20071
20085
20099
20107
20114
20123
20143
20151
20162
20171
20186
20198
20209
20218
202212
202310
202436
202535
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed174

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S25
Eli Lilly and Company18
Amgen9
Pfizer7
AstraZeneca6
BrightGene Bio-Medical Technology Co., Ltd.5
Vincentage Pharma Co., Ltd5
Zealand Pharma4
Altimmune, Inc.3
Boehringer Ingelheim3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight174
Obesity150
Diabetes Mellitus, Type 220
Diabetes Mellitus7
Body Weight5
Non-alcoholic Fatty Liver Disease5
Weight Loss5
Metabolic Diseases4
Hypercholesterolemia3
Nutrition Disorders3

Trials

Showing 1 to 25 of 174. Each trial links to its page on Pharma Observatory.

74 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.